Clinical trial NCT06546878: Cardiac Rehabilitation: Optimisation of the Functional Capacity of Patients Hospitalized With Cardiac Disease
Official title: Cardiac Rehabilitation: Optimisation of the Functional Capacity of Patients Hospitalized With Cardiac Disease
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Myocardial Ischemia
Heart Diseases
Keywords: Cardiac Rehabilitation
Phase I
Myocardial Ischemia
Rehabilitation Nursing
Lead sponsor: University of Évora
Sponsor class: OTHER
First posted: 2024-08-09
Enrollment: 11
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: The World Health Organization \[WHO\] (2021) states that Cardiovascular Diseases \[CVD\] are the leading cause of death in the world, and in 2019 around 17.9 million deaths were caused by CVD and the national picture is no different. In Portugal, demographic ageing continues to be established by the increase in average life expectancy, which in turn leads to an increase in the percentage of the population with CVDs. Of particular note is Ischemic Heart Disease \[IHD\], which is the second leading cause of death in Portugal In order to prevent and combat the progression of CVD and its complications, Cardiac Rehabilitation \[CR\] programs have emerged as a secondary prevention method supported by relevant scientific evidence. In this sense, the Portuguese Society of Cardiology recognizes the role of the Rehabilitation Nurse Specialist as a crucial element of CR teams.

Objective: To evaluate the effectiveness of the phase I cardiac rehabilitation program in patients hospitalized with ischemic heart disease, in terms of functional capacity.


Eligibility criteria: Inclusion Criteria:

* Patients with Myocardial Ischemia
* Patients who agree to take part in the rehabilitation exercise program
* Patients with the cognitive capacity to understand the instructions given, the exercises to be carried out and the teaching provided
* Patients with clinical and hemodynamic stability
* Patients participating in the rehabilitation exercise program for at least 2 sessions.

Exclusion Criteria:

* Patients who do not meet the safety criteria for exercising after a cardiac event
* Patients with osteoarticular pathology that compromises their ability to exercise.

Primary outcomes:
measure: Activity intolerance
timeFrame: The evaluation will be carried out in the first session before starting the rehabilitation program (t0), and in every session during the program for an average of 1 week until the end of the program (t1).
Secondary outcomes:
measure: Health-related quality of life
timeFrame: The evaluation will be carried out in the first session before starting the rehabilitation program (t0). The second evaluation after finishing the program (t1), on average 1 week.
measure: Distance
timeFrame: The first evaluation is carried out in the first session before starting the rehabilitation program (t0), and in all the sessions during the program, on average 1 week before the end of the program (t1).
Other outcomes:
Locations:
city: Beja
country: Portugal
facility: Beja
Study officials:
affiliation: University of Évora
name: José Moreira, MsC
role: STUDY_CHAIR
References: